Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Boston Scientific agrees to acquire Remon Medical Technologies

Boston Scientific : 26 June, 2007  (New Product)
Boston Scientific has signed a definitive agreement to purchase Remon Medical Technologies
The acquisition is subject to customary closing conditions and completion of due diligence, and is expected to close over the summer.

Remon Medical Technologies, a privately held company based in Caesarea, Israel, is a development stage company focused on creating communication technology for medical device applications.

The company was founded in 1997 and entered into a co-development agreement with Guidant in 2004. Guidant was acquired by Boston Scientific on April 21, 2006.

'Remon Medical Technologies brings to Boston Scientific innovative sensor and wireless communication technology to Boston Scientific, which complements our Cardiac Rhythm Management product line', said Fred Colen, executive vice president, operations and technology, CRM, and chief technology officer.

'This acquisition reflects our commitment to being a leader in the CRM market through the introduction of innovative products and services for the benefit of physicians and their patients'.

'We've spent the last several years developing smart, miniature implants designed to enable physicians to assess and treat a variety of medical conditions in a non-invasive manner', said Hezi Himelfarb, Remon Medical Technologies' chief executive officer.

'The acquisition by Boston Scientific will position Remon as a recognised leader in intra-body wireless communication and help realise the potential of our technology, once integrated into the portfolio of Boston Scientific products'.

Remon's technology uses wireless communications to exchange energy and data with minute devices placed deep inside the body.

These devices monitor a variety of physiological parameters, stimulate tissues and organs or activate other devices, creating therapeutic responses.

Remon's technology platform potentially offers broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery, and drug development.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo